NCT04480879View on ClinicalTrials.gov

Evaluation of AZD8154 Concentrations in Blood

PHASE1TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

September 2, 2020

Study Completion Date

September 2, 2020

Conditions
Asthma
Interventions
DRUG

AZD8154 nebuliser

Nebuliser suspension

DRUG

AZD8154 Monodose DPI presented in capsules

AZD8154 Monodose DPI formulation delivered dose

DRUG

AZD8154 Placebo Monodose DPI presented in capsules

The dose correspond to AZD8154 Monodose DPI formulation

Trial Locations (1)

14050

Research Site, Berlin

Sponsors

Lead Sponsor

AstraZeneca

Collaborators (1)

Parexel
All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY